GB2378693A - Capsules for medicaments, beverages, food colourings and flavours - Google Patents
Capsules for medicaments, beverages, food colourings and flavours Download PDFInfo
- Publication number
- GB2378693A GB2378693A GB0114759A GB0114759A GB2378693A GB 2378693 A GB2378693 A GB 2378693A GB 0114759 A GB0114759 A GB 0114759A GB 0114759 A GB0114759 A GB 0114759A GB 2378693 A GB2378693 A GB 2378693A
- Authority
- GB
- United Kingdom
- Prior art keywords
- capsules
- gellucire
- beverages
- food
- polyethylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 25
- 239000000796 flavoring agent Substances 0.000 title claims abstract description 19
- 235000019634 flavors Nutrition 0.000 title claims abstract description 19
- 239000003814 drug Substances 0.000 title claims abstract description 15
- 235000013305 food Nutrition 0.000 title claims abstract description 13
- 235000013361 beverage Nutrition 0.000 title claims abstract description 12
- 238000004040 coloring Methods 0.000 title claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940079593 drug Drugs 0.000 claims abstract description 8
- 230000002035 prolonged effect Effects 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 claims abstract description 3
- 239000004615 ingredient Substances 0.000 claims abstract 6
- 240000007154 Coffea arabica Species 0.000 claims abstract 5
- 235000016213 coffee Nutrition 0.000 claims abstract 5
- 235000013353 coffee beverage Nutrition 0.000 claims abstract 5
- 244000215068 Acacia senegal Species 0.000 claims abstract 4
- 235000006491 Acacia senegal Nutrition 0.000 claims abstract 4
- 229920000084 Gum arabic Polymers 0.000 claims abstract 4
- 235000010489 acacia gum Nutrition 0.000 claims abstract 4
- 229940068918 polyethylene glycol 400 Drugs 0.000 claims abstract 4
- 235000002566 Capsicum Nutrition 0.000 claims abstract 3
- 240000008574 Capsicum frutescens Species 0.000 claims abstract 3
- 239000001390 capsicum minimum Substances 0.000 claims abstract 3
- 206010011224 Cough Diseases 0.000 claims abstract 2
- 229940035676 analgesics Drugs 0.000 claims abstract 2
- 239000000730 antalgic agent Substances 0.000 claims abstract 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims abstract 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims abstract 2
- 239000000499 gel Substances 0.000 claims description 7
- 239000013543 active substance Substances 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 10
- 235000011187 glycerol Nutrition 0.000 claims 5
- 108010010803 Gelatin Proteins 0.000 claims 4
- 229940088679 drug related substance Drugs 0.000 claims 4
- 239000008273 gelatin Substances 0.000 claims 4
- 229920000159 gelatin Polymers 0.000 claims 4
- 235000019322 gelatine Nutrition 0.000 claims 4
- 235000011852 gelatine desserts Nutrition 0.000 claims 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 3
- 229940092284 cardamom extract Drugs 0.000 claims 3
- 229920001223 polyethylene glycol Polymers 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- 229920001661 Chitosan Polymers 0.000 claims 2
- 229920002907 Guar gum Polymers 0.000 claims 2
- 238000005538 encapsulation Methods 0.000 claims 2
- 235000010417 guar gum Nutrition 0.000 claims 2
- 239000000665 guar gum Substances 0.000 claims 2
- 229960002154 guar gum Drugs 0.000 claims 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 239000008601 oleoresin Substances 0.000 claims 2
- -1 theophylene Chemical compound 0.000 claims 2
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 claims 1
- 102000055006 Calcitonin Human genes 0.000 claims 1
- 108060001064 Calcitonin Proteins 0.000 claims 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
- 229920003148 Eudragit® E polymer Polymers 0.000 claims 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 1
- 239000004698 Polyethylene Substances 0.000 claims 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- 229920006243 acrylic copolymer Polymers 0.000 claims 1
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 229940026622 caffeine 20 mg Drugs 0.000 claims 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims 1
- 229960004015 calcitonin Drugs 0.000 claims 1
- 239000002327 cardiovascular agent Substances 0.000 claims 1
- 229940125692 cardiovascular agent Drugs 0.000 claims 1
- 235000019438 castor oil Nutrition 0.000 claims 1
- 239000004359 castor oil Substances 0.000 claims 1
- 238000002144 chemical decomposition reaction Methods 0.000 claims 1
- 229960001380 cimetidine Drugs 0.000 claims 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 claims 1
- 235000020230 cinnamon extract Nutrition 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 239000000284 extract Substances 0.000 claims 1
- 239000000576 food coloring agent Substances 0.000 claims 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 1
- 229940049654 glyceryl behenate Drugs 0.000 claims 1
- 229960001680 ibuprofen Drugs 0.000 claims 1
- 238000010348 incorporation Methods 0.000 claims 1
- 229960000905 indomethacin Drugs 0.000 claims 1
- 229940125396 insulin Drugs 0.000 claims 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims 1
- 229960000991 ketoprofen Drugs 0.000 claims 1
- 230000000873 masking effect Effects 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 229960002009 naproxen Drugs 0.000 claims 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 claims 1
- 229960001597 nifedipine Drugs 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000000717 retained effect Effects 0.000 claims 1
- 239000001069 triethyl citrate Substances 0.000 claims 1
- 235000013769 triethyl citrate Nutrition 0.000 claims 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims 1
- 235000019154 vitamin C Nutrition 0.000 claims 1
- 239000011718 vitamin C Substances 0.000 claims 1
- 235000021260 warm beverage Nutrition 0.000 abstract description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 240000002943 Elettaria cardamomum Species 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 235000005300 cardamomo Nutrition 0.000 abstract 1
- 239000012876 carrier material Substances 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 150000002314 glycerols Chemical class 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000007904 elastic gelatin capsule Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
- A23F5/243—Liquid, semi-liquid or non-dried semi-solid coffee extract preparations; Coffee gels; Liquid coffee in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/72—Encapsulation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C2210/00—Physical treatment of dairy products
- A23C2210/40—Microencapsulation; Encapsulation of particles
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to the delivery of food colorings, flavors, beverages or medicaments in compositions encapsulated in one-piece soft gel capsules. The capsules shell may rupture in contact with warm drink/water over temperature of 26 degrees centigrade and the contents are released immediately or prolonged to achieve desired effects. The capsules may serve to slowly release their contents. The invention offers better consumer convenience and accuracy of the dosage for beverages, flavors or colorings. The carrier material may be polyethylene glycol 400, glycerol esters of fatty acids or gum acacia and the delivered ingredient may be caffeine, tea, coffee, cardamom, capsicum, cinnamon or medicaments, such as analgesics, NSAID, cough medicines and cardiovascular pharmaceuticals.
Description
<Desc/Clms Page number 1>
METHODS AND COMPOSITIONS OF DELIVERY SYSTEMS FOR MEDICAMENTS, BEVERAGES, FOOD COLOURINGS & FLAVOURS Dr Gursharan S. Moonga, BritHealth Ltd, Business & Technology Centre, Bessemer Drive, Stevenage, Herts., SGl 2DX England Patent Application No. GB 9919323. 7 Filing Date 17"'August 1999 ABSTRACT: The invention relates to the one-piece soft gel capsules and compositions of delivery systems for delivery of medicaments and nutrition substances for absorption in the body through gastrointestinal tract for prolonged action. The other aspect of the invention relates to the delivery of food colorings, flavors and beverages in compositions encapsulated in one-piece soft gel capsules, which can be delivered directly to prepare drinks and foods. The capsules shell ruptures in contact with warm drink/water over temperature of 26 degree centigrade and the contents are released immediately or prolonged to achieve desired effects. The invention offers better consumer convenience and accuracy of the dosage for beverages, flavors or colorings The invention also offers methods for delivery of flavors of over prolonged periods. The invention offers opportunity for pharmaceutical, beverages, foods and flavor industry to formulate new products for consumer's convenience and accurate delivery of the active substance.
BACKGROUND TO THE INVENTION Generally oral administered drug dosage forms include elixirs or drugs in liquid, tablet or hard gelatin capsules containing unit dosage of selected drug requiring dosage of two or three times per day. The slow release enables the drug to be released over an extended period while maintaining sufficient bioavailability. The slow release dosage forms have been used for hard gelatin capsules having enteric-coated pellets therein or compressed into tablets and coated from the outside.
In case of flavors no patent is published to the knowledge of the inventor regarding prolonged release in foods. A Canadian patent No. 888683 relates to Seamless Elastic Gelatin capsule (SEG) dosage form in which the fill material when in contact with water or gastric juice forms micro porous spongy substance, which diffuses the active.
Although the sustained release drug form disclosed in the patent relates to a possible system, there is need and further interest in modified release systems those can be encapsulated in one-piece soft gel capsules. These formulations should deliver the active substance under variable conditions of physiology or environment A US patent dated January 1989 Number 4,800, 083 by Food S etal used fill material of a masticator gum/elastomer having medicament dispersed in the matrix and the active substance absorbed by the body. The system is highly insoluble and mechanism for release was suggested as peristaltic movement in the gastrointestinal tract.
Claims (8)
- CLAIMS The inventor claims ; 1. The methods and compositions of delivery systems for beverages, food colorings and flavors. The active substances are encapsulated in one-piece soft gel capsules and the contents are released in contact with warm water/aq medium of the food or drink. The active substances examined included food colorings, flavors and beverages approved under EEC directive 98.
- 2. The delivery of flavors over extended period by incorporation of one of the followings ; gum acacia, guar gum, chitosan, Gellucire 53/10 (from Gattefose), Methyl cellulose mixed with Gellucire 33/01 and Polyethylene Glycol 400
- 3. The method and composition of delivery systems of drug substances to give prolonged desired effects. The composition included Chitosan or gum acacia or guar gum or Gellucire 53/10 or Glyceryl behenate (from Gattefosse. The active substances examined included Analgesics, NSAID, Cough medicines, and Cardiovascular drugs and some examples include Ibuprofen, Nifedipine, Naproxen, Ketoprofen, theophylene, Cimetidine, Indomethacin and vitamin C etc.The other systems examined included Polyethylene Glycols-Drug substance conjugates suspended in Gellucire 33/01.The viscosity of the formulation was adjusted using triethyl citrate or castor oil or glycerin for encapsulation in soft gel one-piece capsules. The capsules were coated with pH sensitive polymethacrylic/acrylic co-polymers in case of insulin and calcitonin capsules. Pectinate was another material examined for coating of such capsules containing peptide drug substances. The capsules showed delivery of peptides and provided protection in the gut against biological and chemical degradation.
- 4. The use of Eudragit E polymer, Gellucire 33/01 and Polyethylene Glycol 400 for taste and odor masking of drug substances.
- 5. The composition of Tea capsules :INGREDIENTS PER CAPSULE Polyethylene Glycol 400 25mg Gellucire 33/01 20mg Caffeine 20mg Cardamom extract Img Tea colour/flavour, 0.5mg Cinnamon extract 0.5mg Gelatin 54mg Glycerin 25mg Water 8mg The flavor and extracts can be varied to prepare any herbal or other nutritional beverage in capsule form which will dissolve immediately in contact with warm aqueous medium.
- 6. The composition of a Coffee Capsules<Desc/Clms Page number 3>INGREDIENTS PER CAPSULE Coffee powder 100mg Polyethylene Glycol 100mg Gellucire 33/01 50mg Gum acacia 5mg Gelatin 100mg Glycerin 50mg Water 15mg The concentration or dosage of the coffee can be varied in proportion with other ingredients for encapsulation in soft gel capsules. The capsules dissolved immediately in contact with warm water and releasing accurate dosage of the coffee and retained freshness/flavor.
- 7. The composition of a food flavorINGREDIENTS PER CAPSULE Cardamom Extract 2mg Polyethylene Glycol 40mg Gellucire 33/01 35mg Gum Acacia 25mg Gelatin 30mg Glycerin 20mg Water 4mgThe cardamom extract can be replaced with any other flavor approved by EEC directive 98.
- 8. The composition of food coloring capsulesINGREDIENTS PER CAPSULE Oleoresin Capsicum 20mg Polyethylene Glycol 40mg Gellucire 33/01 30mg Gelatin 24mg Glycerin 14mg Water 4mg4'Et..... vC. IRE. i. Q. R. c : J' : ;' Tt- M.. o.. t-k" < U<Desc/Clms Page number 4>The oleoresin capsicum can be replaced with any other coloring approved by EEC directive 98. The dosage can also be varied in proportion with other excepients.CONCLUSION AND DISCUSSION The invention offers opportunity to pharmaceutical industry to formulate slow release formulations in a consumers convenience dosage form in one-piece soft gel capsules, which are tamper evident. The invention opens new opportunities for delivery of peptide drugs.The other aspects of the invention offers opportunities to food, beverages and flavor industries to develop new products which gives consumers convenience and accuracy of the dosage for use in delivery of colorings, flavors and preparation of beverages.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0114759A GB2378693A (en) | 2001-06-16 | 2001-06-16 | Capsules for medicaments, beverages, food colourings and flavours |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0114759A GB2378693A (en) | 2001-06-16 | 2001-06-16 | Capsules for medicaments, beverages, food colourings and flavours |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB0114759D0 GB0114759D0 (en) | 2001-08-08 |
| GB2378693A true GB2378693A (en) | 2003-02-19 |
Family
ID=9916771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0114759A Withdrawn GB2378693A (en) | 2001-06-16 | 2001-06-16 | Capsules for medicaments, beverages, food colourings and flavours |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2378693A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110305779A1 (en) * | 2010-06-10 | 2011-12-15 | Cowan Fred M | Phytochemical combinations that regulate pathological immunity |
| US8092839B2 (en) * | 2004-12-13 | 2012-01-10 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer and other diseases |
| US20130064956A1 (en) * | 2011-09-09 | 2013-03-14 | Bary Lyn Zeller | Shelf Stable, Brewed Beverage Concentrates And Methods Of Making The Same |
| US8431165B2 (en) | 2004-12-13 | 2013-04-30 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer and other diseases |
| US8974848B1 (en) * | 2008-06-26 | 2015-03-10 | Barry W. Carothers | Ingestible product and method for enhancing the appearance and quality of teeth in-vivo |
| WO2019141204A1 (en) * | 2018-01-17 | 2019-07-25 | Nano And Advanced Materials Institute Limited | Nano-crystallized herbal ingredient-containing package and method of preparing herbal decoction |
| EP3556219A1 (en) * | 2018-04-13 | 2019-10-23 | Markus Traxler | Syrup for enhancing hot beverages to turn them into fitness drinks |
| US10863754B2 (en) | 2014-07-03 | 2020-12-15 | Kraft Foods Group Brands Llc | Low water coffee and tea beverage concentrates and methods for making the same |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2407720A1 (en) * | 1977-11-08 | 1979-06-01 | Lipha Lyonnaise Indle Pharmace | Oral sustained-action capsule formulations - of drug and excipient which swells in contact with digestive juices |
| EP0243930A1 (en) * | 1986-05-01 | 1987-11-04 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
| EP0496705A1 (en) * | 1991-01-24 | 1992-07-29 | Emil Flachsmann AG | Composition especially adapted for encapsulation in a solid shell and process for preparing same |
-
2001
- 2001-06-16 GB GB0114759A patent/GB2378693A/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2407720A1 (en) * | 1977-11-08 | 1979-06-01 | Lipha Lyonnaise Indle Pharmace | Oral sustained-action capsule formulations - of drug and excipient which swells in contact with digestive juices |
| EP0243930A1 (en) * | 1986-05-01 | 1987-11-04 | Pharmacaps, Inc. | Gelatin-encapsulated controlled-release composition |
| EP0496705A1 (en) * | 1991-01-24 | 1992-07-29 | Emil Flachsmann AG | Composition especially adapted for encapsulation in a solid shell and process for preparing same |
Non-Patent Citations (3)
| Title |
|---|
| Abstracts of JP 61058537 A (R.P Siila KK) * |
| Abstracts of JP 7242536 A (Toyo Capsule KK) * |
| Abstracts of JP 9157162 A (Sato Pharma) * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8092839B2 (en) * | 2004-12-13 | 2012-01-10 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer and other diseases |
| US8431165B2 (en) | 2004-12-13 | 2013-04-30 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer and other diseases |
| US8974848B1 (en) * | 2008-06-26 | 2015-03-10 | Barry W. Carothers | Ingestible product and method for enhancing the appearance and quality of teeth in-vivo |
| US20110305779A1 (en) * | 2010-06-10 | 2011-12-15 | Cowan Fred M | Phytochemical combinations that regulate pathological immunity |
| US20130064956A1 (en) * | 2011-09-09 | 2013-03-14 | Bary Lyn Zeller | Shelf Stable, Brewed Beverage Concentrates And Methods Of Making The Same |
| CN103917100A (en) * | 2011-09-09 | 2014-07-09 | 卡夫食品集团品牌有限责任公司 | Shelf stable, brewed beverage concentrates and methods of making the same |
| US9277758B2 (en) * | 2011-09-09 | 2016-03-08 | Kraft Foods Group Brands Llc | Liquid coffee beverage concentrate |
| US10863754B2 (en) | 2014-07-03 | 2020-12-15 | Kraft Foods Group Brands Llc | Low water coffee and tea beverage concentrates and methods for making the same |
| WO2019141204A1 (en) * | 2018-01-17 | 2019-07-25 | Nano And Advanced Materials Institute Limited | Nano-crystallized herbal ingredient-containing package and method of preparing herbal decoction |
| EP3556219A1 (en) * | 2018-04-13 | 2019-10-23 | Markus Traxler | Syrup for enhancing hot beverages to turn them into fitness drinks |
Also Published As
| Publication number | Publication date |
|---|---|
| GB0114759D0 (en) | 2001-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3253375B1 (en) | Oral solid cannabinoid formulations, methods for producing and using thereof | |
| US7445795B2 (en) | Delivery device, method of using and method of manufacturing | |
| CA2463250A1 (en) | Edible film | |
| CN102083524A (en) | Microencapsulated delivery system | |
| Karavasili et al. | Patent landscape of pediatric-friendly oral dosage forms and administration devices | |
| GB2378693A (en) | Capsules for medicaments, beverages, food colourings and flavours | |
| AU2021103957A4 (en) | A composition and application thereof | |
| JPWO2004096283A1 (en) | Soft capsule film and soft capsule | |
| US20210228492A1 (en) | Multiparticulate including pharmaceutical or probiotic active ingredients for delivery via a shelf stable liquid dosage form | |
| US20200230067A1 (en) | Suspensions of encapsulated pharmaceuticals and methods of making and using the same | |
| JPH07255436A (en) | Complex beverage | |
| US8834922B2 (en) | Methodology and apparatus for oral dual delivery of homeopathic products and non-homeopathic products | |
| US20220331263A1 (en) | Printed Delivery Device Having Supplements | |
| US9849093B2 (en) | Compositions and methods for administration to subjects with dysphagia | |
| More et al. | Duocapsule and alternative shell material to gelatin: Advancement in capsule formulation | |
| Gvozdeva et al. | Therapeutic Potential of Essential Oils and Their Bioactive Compounds Against Colon Cancer: Focus on Colon-Specific Micro-and Nanocarriers. | |
| EP0152432B1 (en) | Sustained release method and product | |
| US11833182B2 (en) | Sleep product | |
| EP1949900A3 (en) | Controlled release solid formulation for oral administration as single dose sachet and method of preparation thereof | |
| CA2991719C (en) | Pharmaceutical compositions | |
| US7048959B1 (en) | Kinetic beverage for delivery of physiologically active substances | |
| WO2025090448A1 (en) | Capsules for oral and nasal delivery of pharmaceutical products | |
| GB2365336A (en) | Multiple capsules | |
| US20020114834A1 (en) | Method of dispensing a formula with medical or nutritional preparations in the form of initially-reduced-release particles (IRRP) | |
| WO2013058996A1 (en) | Two phase pharmaceutical delivery system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |